FIELD: medicine.
SUBSTANCE: method involves administering Isoniazide on the background of standard drug therapy. Magnetic laser radiation therapy is additionally administered to a patient by irradiating cubital veins with low intensity laser radiation. Biologically active additive of Adaptovit is additionally administered at a dose of 1 drop at 8 and 12 o'clock daily during 15 days. Pulsating laser radiation frequency is equal to 600 Hz with 6-7 W power. Exposure time is equal to 4 min upon each upper extremity. The total magnetic laser radiation therapy treatment course is 8-12 procedures long given in daily mode.
EFFECT: enhanced effectiveness of treatment; accelerated exudates resorption.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH TUBERCULOUS EXUDATIVE PLEURITIS | 2012 |
|
RU2491089C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ENCYSTED TUBERCULOSIS PLEURITIS | 2003 |
|
RU2239437C1 |
METHOD FOR DETERMINING TIMING OF SURGICAL TREATMENT OF TUBERCULOUS PLEURAL EMPYEMA IN CHILDREN | 2021 |
|
RU2756371C1 |
METHOD OF TREATING PATIENTS WITH PLEURAL EFFUSION OF VARIOUS AETIOLOGY | 2013 |
|
RU2570527C2 |
METHOD OF FLUID RESORPTION IN CASE OF TUBERCULOSIS PLEURITES | 2010 |
|
RU2440830C1 |
METHOD FOR PREDICTING EXUDATIVE PLEURISY OF TUBERCULOUS ETIOLOGY | 2007 |
|
RU2321864C1 |
METHOD OF EXUDATIVE PLEURISIES TREATMENT | 2007 |
|
RU2357728C2 |
METHOD OF SUPPURATIVE PLEURISY DIAGNOSTICS | 2007 |
|
RU2327989C1 |
METHOD OF SUPPURATIVE COMPLICATION DIAGNOSTICS BY EXUDATE PLEURISY | 2007 |
|
RU2327999C1 |
METHOD FOR TREATING TUBERCULOUS PLEURISY CASES | 2006 |
|
RU2295341C1 |
Authors
Dates
2006-09-10—Published
2005-05-25—Filed